Related Experiment Videos
[Calciuretic renal function in patients with essential hypertension]
Insights
Essential hypertension (EH) patients show impaired calcium excretion regulation due to parathyroid hormone (PTH) resistance. Supplementation normalizes renal function and lowers blood pressure.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Context:
- Essential hypertension (EH) is a common cardiovascular condition.
- Calcium homeostasis is regulated by parathyroid hormone (PTH) and calcitonin.
- Renal calciuresis plays a role in maintaining calcium balance.
Purpose:
- To investigate the calciuretic response to hypercalcemia in EH patients.
- To explore the relationship between parathyroid hormone (PTH) and renal tubular calcium reabsorption in EH.
- To assess the therapeutic potential of calcium supplementation in EH.
Summary:
- EH patients exhibit impaired renal calcium excretion, particularly inadequate suppression of tubular reabsorption by PTH during hypercalcemia.
- Hormonal-renal correlations differ in EH patients compared to healthy individuals, showing reduced sensitivity to calcium-regulating hormones (CRH) at the tubular level.
- Prolonged calcium administration in EH patients normalizes calciuretic renal function, enhances resistance to calcemia fluctuations, lowers arterial pressure, and reduces the need for calcium antagonists.
Impact:
- Calcium supplementation may offer a novel therapeutic strategy for managing essential hypertension.
- Understanding altered calcium metabolism in EH can lead to improved patient outcomes.
- This research highlights the complex interplay between calcium regulation, renal function, and hypertension.
Abstract:
Under the conditions of standard and customary calcium use, patients suffering from essential hypertension (EH) do not manifest any changes in calciuresis either at the expense of the glomerular or tubular mechanisms. After intravenous hypercalcemic injections EH patients demonstrate well-defined disorders in calciuretic renal function, caused by inadequate suppression of tubular reabsorption of calcium by parathyroid hormone (PTH). The hormonal-renal correlations in EH patients differ from those in normals. More pronounced alterations in the concentration of radioimmune PTH and calcitonin under acute hypercalcemia are not associated with an adequate increment of fractional excretion of calcium whereas the calciuretic effect of exogenous calcium-regulating hormones (CRH) realized at the tubular level is less remarkable. Therefore EH patients manifest changes not only in CRH secretion but also in the sensitivity to them of the renal tubules. White changing parathyroid regulation of calcium metabolism prolonged administration of calcium to EH patients enhances body capabilities of resisting acute alterations in calcemia because of normalization of calciuretic renal function, especially tubular calcium transport. In addition, it lowers arterial pressure and enables reduction of the dose of calcium antagonists used in the treatment of EH.